Pretreatment neutrophil-to-lymphocyte ratio is associated with immunotherapy efficacy in patients with advanced cancer: a systematic review and meta-analysis
Authors:
Top Cited Papers
Open Access
- 2 January 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-17
Abstract
This study aimed to systematically investigate the value of the pre-treatment neutrophil-to-lymphocyte ratio (NLR) in prognosticating the outcome of patients with advanced cancer receiving immunotherapy. We searched Embase, PubMed, Web of Science, and Cochrane Library to identify studies about cancer patients with immunotherapy until November 29, 2024. Retrospective or prospective cohort studies with pretreatment NLR data were included. The odds ratio (OR) and 95% confidence interval (CI) were calculated to evaluate the predictive value of NLR in prognosis and immunotherapy efficacy. The random effect model was applied for meta-analysis and the risk of bias was assessed by Egger test and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) method. A total of 129 articles involving 18780 cases were finally selected. Most cases were advanced cancers with the median follow-up period ranged 2–48.6 months. The high pretreatment NLR level was associated with the significantly reduced OS (HR (95%CI) = 2.26 (2.03, 2.53)), PFS (HR (95% CI) = 1.83 (1.69, 1.98)), ORR (OR (95%CI) = 0.53 (0.46, 0.61)) and DCR (OR (95% CI) = 0.36 (0.29, 0.43)) in patients with advanced cancer receiving immunotherapy. The quality of evidence was low, attributed to the serious risk of bias and incon¬sistency. An elevated NLR before immunotherapy was significantly associated with poor clinical outcomes in patients with advanced cancer.Keywords
Funding Information
- Natural Science Foundation of Hunan Province National Health Commission (B202303027655)
- Natural Science Foundation of Changsha Science and technology Bureau (Kq2208150)
- Wu JiePing Foundation of China (320.6750.2022-22-59)
- Guangdong Association of Clinical Trials (GACT)/Chinese Thoracic Oncology Group (CTONG) and Guangdong Provincial Key Lab of Translational Medicine in Lung Cancer (2017B030314120)
This publication has 168 references indexed in Scilit:
- The past, present and future of immunotherapy against tumor2015
- Baseline neutrophil-to-lymphocyte ratio is associated with outcome of ipilimumab-treated metastatic melanoma patientsBritish Journal of Cancer, 2015
- Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganismsNature Reviews Cancer, 2013
- Neutrophil to lymphocyte ratio may be predict of mortality in all conditionsBritish Journal of Cancer, 2013
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysisBritish Journal of Cancer, 2011
- Immunity, Inflammation, and CancerCell, 2010
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Inflammation and cancer: An ancient link with novel potentialsInternational Journal of Cancer, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Bias in meta-analysis detected by a simple, graphical testBMJ, 1997